רספרים

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

SULPHAMETHOXAZOLE; TRIMETHOPRIM

Mevcut itibaren:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATC kodu:

J01EE01

Farmasötik formu:

תרחיף

Kompozisyon:

SULPHAMETHOXAZOLE 200 MG / 5 ML; TRIMETHOPRIM 40 MG / 5 ML

Uygulama yolu:

פומי

Reçete türü:

מרשם נדרש

Tarafından üretildi:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Terapötik grubu:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Terapötik alanı:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Terapötik endikasyonlar:

Treatment of urinary tract infections due to susceptible strains of the following organisms: - Escherichia coli - Klebsiella - Enterobacter - Proteus mirabilis - Proteus vulgaris - Proteus morganii. Treatment of acute otitis media in children due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. To date there are limited data available as to the safety of repeated use of Resprim in infants under 2 years of age. Resprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. Treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei. Resprim is also indicated in the treatment of documented Pneumocystis carinii pneumonitis.

Yetkilendirme tarihi:

2012-01-31